Krka ups Jan-Sep revenue 7%, net profit 19% y/y

Novo Mesto, 14 November - The pharmaceutical group Krka generated EUR 1.43 billion in revenue in the first nine months of the year, an increase of 7% over the same period in 2023, the group's unaudited interim report shows. The group reports a profit of EUR 281 million, which was 19% more year-on-year.